USANA Health Sciences Net Profit Margin 2006-2019 | USNA

USANA Health Sciences net profit margin from 2006 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
USANA Health Sciences Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-06-30 $1.13B $0.11B 9.60%
2019-03-31 $1.17B $0.12B 10.34%
2018-12-31 $1.19B $0.13B 10.60%
2018-09-30 $1.16B $0.09B 7.57%
2018-06-30 $1.13B $0.08B 7.18%
2018-03-31 $1.08B $0.07B 6.46%
2017-12-31 $1.05B $0.06B 5.92%
2017-09-30 $1.03B $0.09B 8.76%
2017-06-30 $1.02B $0.10B 9.42%
2017-03-31 $1.02B $0.10B 9.70%
2016-12-31 $1.01B $0.10B 9.94%
2016-09-30 $0.99B $0.10B 10.34%
2016-06-30 $0.97B $0.10B 10.16%
2016-03-31 $0.94B $0.10B 10.33%
2015-12-31 $0.92B $0.10B 10.35%
2015-09-30 $0.91B $0.09B 10.08%
2015-06-30 $0.87B $0.09B 9.75%
2015-03-31 $0.83B $0.08B 9.55%
2014-12-31 $0.79B $0.08B 9.62%
2014-09-30 $0.75B $0.08B 10.03%
2014-06-30 $0.73B $0.07B 10.00%
2014-03-31 $0.73B $0.08B 10.67%
2013-12-31 $0.72B $0.08B 11.00%
2013-09-30 $0.70B $0.08B 10.98%
2013-06-30 $0.69B $0.08B 11.13%
2013-03-31 $0.66B $0.07B 10.54%
2012-12-31 $0.65B $0.07B 10.17%
2012-09-30 $0.63B $0.06B 9.74%
2012-06-30 $0.61B $0.06B 9.26%
2012-03-31 $0.59B $0.05B 8.94%
2011-12-31 $0.58B $0.05B 8.58%
2011-09-30 $0.58B $0.05B 8.52%
2011-06-30 $0.57B $0.05B 8.83%
2011-03-31 $0.54B $0.05B 8.66%
2010-12-31 $0.52B $0.05B 8.88%
2010-09-30 $0.50B $0.04B 8.85%
2010-06-30 $0.47B $0.04B 8.25%
2010-03-31 $0.46B $0.04B 8.06%
2009-12-31 $0.44B $0.03B 7.78%
2009-09-30 $0.43B $0.03B 6.50%
2009-06-30 $0.43B $0.03B 6.56%
2009-03-31 $0.42B $0.03B 6.84%
2008-12-31 $0.43B $0.03B 6.76%
2008-09-30 $0.43B $0.04B 8.43%
2008-06-30 $0.43B $0.04B 9.15%
2008-03-31 $0.43B $0.04B 9.41%
2007-12-31 $0.42B $0.05B 10.61%
2007-09-30 $0.41B $0.04B 10.73%
2007-06-30 $0.40B $0.04B 10.86%
2007-03-31 $0.38B $0.04B 11.11%
2006-12-31 $0.37B $0.04B 10.96%
2006-09-30 $0.34B $0.04B 11.63%
2006-06-30 $0.33B $0.04B 11.98%
2006-03-31 $0.33B $0.04B 12.27%
2005-12-31 $0.32B $0.04B 12.38%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.516B $1.189B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.530B 37.28
Astellas Pharma (ALPMY) Japan $26.750B 13.12
Takeda Pharmaceutical (TAK) Japan $26.248B 8.20
Grifols, S.A (GRFS) Spain $15.195B 19.39
UCB SA (UCBJF) Belgium $15.008B 0.00
Eisai (ESALY) Japan $14.512B 24.95
Merck (MKGAF) Germany $13.654B 18.63
Ionis Pharmaceuticals (IONS) United States $9.835B 21.21
Ono Pharmaceutical (OPHLF) Japan $9.383B 20.06
Neurocrine Biosciences (NBIX) United States $9.041B 0.00
IPSEN SA ADR (IPSEY) France $8.570B 0.00
Sage Therapeutics (SAGE) United States $8.490B 0.00
Catalent (CTLT) United States $8.196B 32.90
Jazz Pharmaceuticals (JAZZ) Ireland $7.686B 10.11
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 19.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.781B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.894B 17.59
FibroGen (FGEN) United States $3.948B 98.74
United Therapeutics (UTHR) United States $3.588B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.197B 73.30
Taro Pharmaceutical Industries (TARO) Israel $3.174B 11.38
Nektar Therapeutics (NKTR) United States $3.132B 0.00
Evotec AG (EVTCY) Germany $3.127B 42.81
Tilray (TLRY) Canada $2.910B 0.00
PTC Therapeutics (PTCT) United States $2.741B 0.00
Xencor (XNCR) United States $2.298B 50.10
Zogenix (ZGNX) United States $2.161B 0.00
Portola Pharmaceuticals (PTLA) United States $2.046B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.578B 57.42
CLINIGEN GP (CLIGF) United Kingdom $1.577B 0.00
Corcept Therapeutics (CORT) United States $1.490B 20.48
Enanta Pharmaceuticals (ENTA) United States $1.421B 23.44
Heron Therapeutics (HRTX) United States $1.417B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.405B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.207B 0.00
Aerie Pharmaceuticals (AERI) United States $1.097B 0.00
ArQule (ARQL) United States $1.074B 0.00
Radius Health (RDUS) United States $1.063B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.933B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.855B 3.81
TherapeuticsMD (TXMD) United States $0.680B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.616B 0.00
Endo (ENDP) Ireland $0.577B 1.02
Akebia Therapeutics (AKBA) United States $0.574B 0.00
Karyopharm Therapeutics (KPTI) United States $0.572B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.545B 0.00
Concordia (CXRXF) Canada $0.533B 0.00
Indivior (INVVY) United States $0.520B 1.88
Aptorum Group (APM) China $0.467B 0.00
Dermira (DERM) United States $0.466B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.460B 0.00
Organogenesis Holdings (ORGO) United States $0.453B 0.00
Dova Pharmaceuticals (DOVA) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.432B 19.67
ImmunoGen (IMGN) United States $0.427B 0.00
Flexion Therapeutics (FLXN) United States $0.418B 0.00
Translate Bio (TBIO) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.412B 0.96
ChemoCentryx (CCXI) United States $0.412B 0.00
Collegium Pharmaceutical (COLL) United States $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.374B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.370B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.334B 0.00
Xeris Pharmaceuticals (XERS) United States $0.315B 0.00
CV Sciences (CVSI) United States $0.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.296B 0.00
KalVista Pharmaceuticals (KALV) United States $0.288B 0.00
CannTrust Holdings (CTST) Canada $0.286B 0.00
Harpoon Therapeutics (HARP) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Lannett Co Inc (LCI) United States $0.272B 2.64
La Jolla Pharmaceutical (LJPC) United States $0.270B 0.00
OptiNose (OPTN) United States $0.269B 0.00
DURECT (DRRX) United States $0.261B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.258B 0.00
Recro Pharma (REPH) United States $0.253B 0.00
Concert Pharmaceuticals (CNCE) United States $0.252B 0.00
Calithera Biosciences (CALA) United States $0.220B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Molecular Templates (MTEM) United States $0.188B 0.00
Ardelyx (ARDX) United States $0.187B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.185B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 29.48
Taiwan Liposome (TLC) Taiwan $0.171B 0.00
Redhill Biopharma (RDHL) Israel $0.152B 0.00
IMV INC (IMV) Canada $0.151B 0.00
GlycoMimetics (GLYC) United States $0.151B 0.00
Generex Biotechnology (GNBT) United States $0.138B 0.00
Majesco Entertainment (PTE) United States $0.134B 0.00
Jounce Therapeutics (JNCE) United States $0.127B 0.00
MEI Pharma (MEIP) United States $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.125B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.121B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.111B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.104B 0.00
AgeX Therapeutics (AGE) United States $0.103B 0.00
Cardiome Pharma (CORV) Canada $0.101B 0.00
Iterum Therapeutics (ITRM) Ireland $0.096B 0.00
Mast Therapeutics (SVRA) United States $0.096B 0.00
Neos Therapeutics (NEOS) United States $0.093B 0.00
Aquestive Therapeutics (AQST) United States $0.093B 0.00
Nivalis Therapeutics (ALPN) United States $0.089B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 31.82
MediWound (MDWD) Israel $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.081B 0.00
RENEURON GP (RNUGF) United Kingdom $0.080B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.076B 0.00
Natural Alternatives (NAII) United States $0.075B 7.52
China SXT Pharmaceuticals (SXTC) China $0.072B 0.00
Otonomy (OTIC) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 584.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Capnia (SLNO) United States $0.061B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Pharmaxis (PXSLY) Australia $0.060B 0.00
SCYNEXIS (SCYX) United States $0.060B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
India Globalization Capital (IGC) United States $0.042B 0.00
CTI BioPharma (CTIC) United States $0.039B 0.00
Aclaris Therapeutics (ACRS) United States $0.038B 0.00
Melinta Therapeutics (MLNT) United States $0.037B 0.00
Bio-Path Holdings (BPTH) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
PharmAthene (ALT) United States $0.034B 0.00
Biomerica (BMRA) United States $0.030B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
Opexa Therapeutics (ACER) United States $0.022B 0.00
IsoRay (ISR) United States $0.022B 0.00
Heat Biologics (HTBX) United States $0.019B 0.00
HANCOCK JAFFE (HJLI) United States $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 1.43
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Shineco (TYHT) China $0.014B 0.00
Onconova Therapeutics (ONTX) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.006B 0.00
Flex Pharma (SLRX) United States $0.005B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Xenetic Biosciences (XBIO) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00